Evidence map›Paper›PMID 41733828›Full record

ArticleDigestive diseases and sciences2026

Not Just for Volume Anymore: New Indications for Albumin in Patients with Liver Disease.

Manuela Merli, Simone Di Cola

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Manuela MerliDepartments of Translational and Precision Medicine, University of Rome Sapienza, Viale Dell'Universita' 37, 00185, Rome, Italy. manuela.merli@uniroma1.it.
Simone Di ColaDepartments of Translational and Precision Medicine, University of Rome Sapienza, Viale Dell'Universita' 37, 00185, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether albumin administration may counter chronic inflammation due to its pleiotropic effects is still a matter of investigation. Infusions which might be efficacious for this purpose in patients with liver cirrhosis are still unknown.

Indexed as

AlbuminsLiver CirrhosisLiver DiseasesAscitesHumansAlbuminsAcute kidney injuryAntioxidant activityAscitesAssociated molecular patternsDamageEncephalopathyHyponatremiaLike receptorsPathogenSpontaneous bacterial peritonitisSystemic inflammationTollVariceal hemorrhage

Identifiers

PMID41733828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.